Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jul. 25, 2026	Jul. 26, 2025	Jul. 27, 2024
REVENUE:
Total revenue	$ 63,325	$ 56,654	$ 53,803
COST OF SALES:
Total cost of sales	22,465	19,864	18,975
GROSS MARGIN	40,860	36,790	34,828
OPERATING EXPENSES:
Research and development	9,563	9,300	7,983
Sales and marketing	11,559	10,966	10,364
General and administrative	2,761	2,992	2,813
Amortization of purchased intangible assets	916	1,028	698
Restructuring and other charges	693	744	789
Total operating expenses	25,492	25,030	22,647
OPERATING INCOME	15,368	11,760	12,181
Interest income	866	1,001	1,365
Interest expense	(1,470)	(1,593)	(1,006)
Other income (loss), net	1,245	(68)	(306)
Interest and other income (loss), net	641	(660)	53
INCOME BEFORE PROVISION FOR INCOME TAXES	16,009	11,100	12,234
Provision for income taxes	2,742	920	1,914
NET INCOME	$ 13,267	$ 10,180	$ 10,320
Net income per share:
Basic (in dollars per share)	$ 3.36	$ 2.56	$ 2.55
Diluted (in dollars per share)	$ 3.33	$ 2.55	$ 2.54
Shares used in per-share calculation:
Basic (in shares)	3,953	3,976	4,043
Diluted (in shares)	3,987	3,998	4,062
Product
REVENUE:
Total revenue	$ 48,295	$ 41,608	$ 39,253
COST OF SALES:
Total cost of sales	17,781	15,121	14,339
Services
REVENUE:
Total revenue	15,030	15,046	14,550
COST OF SALES:
Total cost of sales	$ 4,684	$ 4,743	$ 4,636

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jul. 25, 2026	Jul. 26, 2025	Jul. 27, 2024
Cash flows from operating activities:
Net income	$ 13,267	$ 10,180	$ 10,320
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization, and other	2,540	2,811	2,507
Share-based compensation expense	3,830	3,641	3,074
Provision for receivables	23	24	34
Deferred income taxes	226	(1,133)	(972)
(Gains) losses on divestitures, investments and other, net	(1,358)	(38)	215
Change in operating assets and liabilities, net of effects of acquisitions and divestitures:
Accounts receivable	(832)	(22)	(289)
Inventories	(2,541)	209	275
Financing receivables	(1,835)	214	76
Other assets	(1,032)	(499)	(671)
Accounts payable	842	257	(90)
Income taxes, net	(2,304)	(1,839)	(4,539)
Accrued compensation	457	(53)	(696)
Deferred revenue	1,125	248	1,220
Other liabilities	1,769	193	416
Net cash provided by operating activities	14,177	14,193	10,880
Cash flows from investing activities:
Purchases of investments	(8,974)	(4,589)	(4,230)
Proceeds from sales of investments	2,013	2,643	4,136
Proceeds from maturities of investments	6,105	4,943	6,367
Acquisitions, net of cash and cash equivalents acquired and divestitures	(516)	(291)	(25,994)
Purchases of non-marketable equity securities	(946)	(383)	(284)
Return of investments in non-marketable equity securities	270	306	202
Acquisition of property and equipment	(1,410)	(905)	(670)
Other	(26)	9	(5)
Net cash provided by (used in) investing activities	(3,484)	1,733	(20,478)
Cash flows from financing activities:
Issuances of common stock	805	736	714
Repurchases of common stock - repurchase program	(6,106)	(6,000)	(5,787)
Shares repurchased for tax withholdings on vesting of restricted stock units	(1,873)	(1,222)	(992)
Short-term borrowings, original maturities of 90 days or less, net	616	(31)	478
Issuances of debt	13,048	19,292	31,818
Repayments of debt	(12,251)	(22,073)	(9,826)
Repayments of Splunk convertible debt, net of capped call proceeds	0	0	(3,140)
Dividends paid	(6,553)	(6,437)	(6,384)
Other	(33)	(80)	(37)
Net cash provided by (used in) financing activities	(12,347)	(15,815)	6,844
Effect of foreign currency exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents	(29)	(43)	(31)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	(1,683)	68	(2,785)
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of fiscal year	8,910	8,842	11,627
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of fiscal year	$ 7,227	$ 8,910	$ 8,842

Consolidated Balance Sheets - USD ($) $ in Millions	Jul. 25, 2026	Jul. 26, 2025
Current assets:
Cash and cash equivalents	$ 7,218	$ 8,346
Investments	8,700	7,764
Accounts receivable, net of allowance of $78 at July 25, 2026 and $69 at July 26, 2025	7,470	6,701
Inventories	5,694	3,164
Financing receivables, net	3,392	3,061
Other current assets	6,191	5,950
Total current assets	38,665	34,986
Property and equipment, net	2,760	2,113
Financing receivables, net	4,940	3,466
Goodwill	59,477	59,136
Purchased intangible assets, net	7,557	9,175
Deferred tax assets	7,109	7,356
Other assets	9,129	6,059
TOTAL ASSETS	129,637	122,291
Current liabilities:
Short-term debt	10,161	5,232
Accounts payable	3,366	2,528
Income taxes payable	190	1,857
Accrued compensation	4,057	3,611
Deferred revenue	16,988	16,416
Other current liabilities	6,763	5,420
Total current liabilities	41,525	35,064
Long-term debt	19,372	22,861
Income taxes payable	2,339	2,165
Deferred revenue	12,793	12,363
Other long-term liabilities	3,323	2,995
Total liabilities	79,352	75,448
Commitments and contingencies (Note 13)
Cisco stockholders’ equity:
Preferred stock, $0.001 par value: 5 shares authorized; none issued and outstanding	0	0
Common stock and additional paid-in capital, $0.001 par value: 20,000 shares authorized; 3,946 and 3,960 shares issued and outstanding at July 25, 2026 and July 26, 2025, respectively	49,676	47,747
Retained earnings	1,565	50
Accumulated other comprehensive loss	(956)	(954)
Total equity	50,285	46,843
TOTAL LIABILITIES AND EQUITY	$ 129,637	$ 122,291